FGD1

Chr X

FYVE, RhoGEF and PH domain containing 1

Also known as: AAS, FGDY, MRXS16, ZFYVE3

This gene encodes a protein that contains Dbl (DH) and pleckstrin (PH) homology domains and is similar to the Rho family of small GTP-binding proteins. The encoded protein specifically binds to the Rho family GTPase Cdc42Hs and can stimulate the GDP-GTP exchange of the isoprenylated form of Cdc42Hs. It also stimulates the mitogen activated protein kinase cascade leading to c-Jun kinase SAPK/JNK1 activation. Defects in this gene are the cause of the faciogenital dysplasia in Aarskog-Scott syndrome and a syndromatic form of X-linked cognitive disability. [provided by RefSeq, Jul 2017]

ResearchGenerating clinical summary…
LOFmechanismLOEUF 0.20
Clinical SummaryFGD1
🧬
Gene-Disease Validity (ClinGen)
Aarskog-Scott syndrome, X-linked · XLDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.20LOEUF
pLI 1.000
Z-score 4.92
OE 0.06 (0.030.20)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
3.52Z-score
OE missense 0.52 (0.460.58)
215 obs / 417.2 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.06 (0.030.20)
00.351.4
Missense OE?0.52 (0.460.58)
00.61.4
Synonymous OE?0.97
01.21.6
LoF obs/exp: 2 / 32.0Missense obs/exp: 215 / 417.2Syn Z: 0.35
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveFGD1-related Aarskog-Scott syndromeLOFXLR

This gene — mechanism propensity

DN
0.2698th %ile
GOF
0.5268th %ile
LOF
0.76top 10%

The highest-scoring mechanism for this gene is loss-of-function (haploinsufficiency).

LOFprediction above median · LOEUF 0.20 · ClinGen HI: Sufficient evidence for dosage pathogenicity

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

FGD1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →